Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

18.03
-1.4600-7.49%
Post-market: 18.690.6600+3.66%19:41 EDT
Volume:2.89M
Turnover:52.88M
Market Cap:6.31B
PE:-18.57
High:19.59
Open:19.25
Low:18.00
Close:19.49
52wk High:24.28
52wk Low:1.33
Shares:349.76M
Float Shares:242.90M
Volume Ratio:0.75
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:17.43
PE(LYR):-41.05

Loading ...

U.S. Stocks on the Move-lulu's Fashion Lounge Holdings, Wells Fargo, Bank of America

Reuters
·
Jul 14

Erasca Inc : Piper Sandler Raises Target Price to $22 from $18

THOMSON REUTERS
·
Jul 14

Cancer Biotech Erasca Down Premarket After $550 Mln Share Sale

Reuters
·
Jul 14

Analyst Maintains Buy Rating and $20 Price Target on Erasca as ERAS-0015 Data Bolster Foundational pan‑RAS Therapy Thesis

TIPRANKS
·
Jul 14

Erasca Plans to Fund R&D for Oncology Pipeline with Net Proceeds from USD 550 Million Stock Offering

Reuters
·
Jul 14

Erasca Announces Pricing of Upsized Public Offering of Common Stock

THOMSON REUTERS
·
Jul 14

Erasca - Prices Public Offering at $17.5 Per Share

THOMSON REUTERS
·
Jul 14

Erasca Shares Down 3.5% After the Bell; Announces Proposed Public Offering of $500 Mln of Common Stock

THOMSON REUTERS
·
Jul 14

Erasca Plans USD 500 Million Common Stock Offering

Reuters
·
Jul 14

Erasca Reports 57% Preliminary Response Rate for Eras-0015 in 2L+ KRAS G12X Pancreatic Cancer Trial

Reuters
·
Jul 14

Erasca files automatic mixed securities shelf

TIPRANKS
·
Jul 14

Erasca Announces Proposed Public Offering of $500 Million of Common Stock

THOMSON REUTERS
·
Jul 14

Erasca Inc: Files for Mixed Shelf Offering, Size not Disclosed - Filing

THOMSON REUTERS
·
Jul 14

Erasca announces updated preliminary ERAS-0015 data

TIPRANKS
·
Jul 14

Erasca Announces Updated Preliminary Phase 1 Data and Registration-enabling Plans for Potentially Best-in-class Pan-ras Molecular Glue Eras-0015 in Kras-mutant Solid Tumors

THOMSON REUTERS
·
Jul 14

Erasca Inc: Additional Eras-0015 Monotherapy and Combination Data Expected H1 2027

THOMSON REUTERS
·
Jul 14

Erasca - Plans Registration-enabling Lung Cancer Trial in H1 2027; Phase 3 Pancreatic Cancer Trial in 2027

THOMSON REUTERS
·
Jul 14

Erasca Notifies Availability of Press Release on Updated Phase 1 Eras-0015 Data and Trial Plans

Reuters
·
Jul 14

Erasca initiated with Early Stage Biotech at Goldman Sachs

TIPRANKS
·
Jul 13

Robinhood and 4 More Stocks That were Just Added to This Firm's 'Top Picks' List

Dow Jones
·
Jul 02